Cargando…

Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients

Fabry disease (FD), a rare X‐linked disease, can be treated with bi‐monthly infusion of enzyme replacement therapy (ERT) to replace deficient α‐galactosidase A (AGAL‐A). ERT reduces symptoms, improves quality of life (QoL), and improves clinical signs and biochemical markers. ERT initiation in child...

Descripción completa

Detalles Bibliográficos
Autores principales:	Germain, Dominique P., Fouilhoux, Alain, Decramer, Stéphane, Tardieu, Marine, Pillet, Pascal, Fila, Marc, Rivera, Serge, Deschênes, Georges, Lacombe, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852597/ https://www.ncbi.nlm.nih.gov/pubmed/30941742 http://dx.doi.org/10.1111/cge.13546

Ejemplares similares

Treatment needs and expectations for Fabry disease in France: development of a new Patient Needs Questionnaire
por: Noël, Esther, et al.
Publicado: (2019)

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
por: Biegstraaten, Marieke, et al.
Publicado: (2015)

Recommended respiratory tests are not routinely performed for mucopolysaccharidosis patients
por: Denamur, Sophie, et al.
Publicado: (2021)

Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment
por: Politei, Juan M., et al.
Publicado: (2016)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Late-onset Fabry disease revealed by ventricular tachycardia: A case report
por: Ditac, Geoffroy, et al.
Publicado: (2021)

Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease
por: Germain, Dominique P., et al.
Publicado: (2021)

Semen and male genital tract characteristics of patients with Fabry disease: the FERTIFABRY multicentre observational study
por: Papaxanthos-Roche, Aline, et al.
Publicado: (2019)

Primary Molecular Disorders and Secondary Biological Adaptations in Bartter Syndrome
por: Deschênes, Georges, et al.
Publicado: (2011)

Immunoadsorption for paediatric post-diarrhoea haemolytic-uraemic syndrome with severe neurological involvement
por: Pietrement, C., et al.
Publicado: (2012)

Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group
por: Gal, Andreas, et al.
Publicado: (2011)

Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study
por: Bichet, Daniel G., et al.
Publicado: (2023)

National Consensus for the Management of Acute Gastroenteritis in Jordanian Children: Consensus Recommendations Endorsed by the Jordanian Paediatric Society
por: Rawashdeh, Mohammed, et al.
Publicado: (2022)

Aortic arch stiffness in Fabry disease
por: Bensalah, Zoubir M, et al.
Publicado: (2013)

Fabry disease and COVID-19: International expert recommendations for management based on real-world experience
por: Laney, Dawn A., et al.
Publicado: (2021)

Fabry disease and COVID-19: international expert recommendations for management based on real-world experience
por: Laney, Dawn A, et al.
Publicado: (2020)

Brazilian consensus recommendations for the diagnosis, screening, and treatment of individuals with fabry disease: Committee for Rare Diseases - Brazilian Society of Nephrology/2021
por: Silva, Cassiano Augusto Braga, et al.
Publicado: (2022)

Paediatric Fabry disease: prognostic significance of ocular changes for disease severity
por: Kalkum, Gisela, et al.
Publicado: (2016)

Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)
por: Kneyber, Martin C. J., et al.
Publicado: (2017)

Cytomegalovirus infection can mimic genetic nephrotic syndrome: a case report
por: Hogan, Julien, et al.
Publicado: (2015)

Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb(3)) in Fabry Transgenic Mice and in the Plasma of Fabry Patients
por: Young-Gqamana, Brandy, et al.
Publicado: (2013)

Case Report: First Two Identified Cases of Fabry Disease in Central Asia
por: Cainelli, Francesca, et al.
Publicado: (2021)

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
por: Ortiz, Alberto, et al.
Publicado: (2016)

Ascending aorta dilatation common feature which correlate with left ventricular hypertrophy in fabry disease
por: Bensalah, Mourad, et al.
Publicado: (2011)

Conventional radiography in juvenile idiopathic arthritis: Joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology
por: Marteau, Pauline, et al.
Publicado: (2018)

Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype–phenotype workgroup
por: Germain, Dominique P, et al.
Publicado: (2020)

Fabry disease: Four case reports of meningioma and a review of the literature on other malignancies
por: Thurberg, Beth L., et al.
Publicado: (2016)

Heidelberg Consensus Recommendations on Trustmarks
Publicado: (2000)

A rare late progression form of Sly syndrome mucopolysaccharidosis
por: Guffon, Nathalie, et al.
Publicado: (2019)

Improvement of gastrointestinal symptoms in a significant proportion of male patients with classic Fabry disease treated with agalsidase beta: A Fabry Registry analysis stratified by phenotype
por: Hopkin, Robert J., et al.
Publicado: (2020)

Heart failure in Fabry disease revisited: application of current heart failure guidelines and recommendations
por: Rob, Daniel, et al.
Publicado: (2022)

Consensus Recommendations on Training and Competing in the Heat
por: Racinais, Sébastien, et al.
Publicado: (2015)

Consensus recommendations on training and competing in the heat
por: Racinais, S, et al.
Publicado: (2015)

Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience
por: Gragnaniello, Vincenza, et al.
Publicado: (2021)

Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients
por: Germain, Dominique P, et al.
Publicado: (2002)

Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panel
por: Stepien, Karolina M., et al.
Publicado: (2023)

The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities
por: Brosseau, Jean-Philippe, et al.
Publicado: (2018)

Newborn hearing screening programme in Belgium: a consensus recommendation on risk factors
por: Vos, Bénédicte, et al.
Publicado: (2015)

Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease
por: Mauhin, Wladimir, et al.
Publicado: (2022)

Recommendations for neonatologist performed echocardiography in Europe: Consensus Statement endorsed by European Society for Paediatric Research (ESPR) and European Society for Neonatology (ESN)
por: de Boode, Willem P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gkpqvcf412bqnunop4cs355o7j